Investigating the effectiveness of Ozone Hemotherapy on the respiratory condition of patients

Phase 3

Conditions: Covid 19.
covid-19 diseaes
U07.1

Registration Number: IRCT20200504047298N4

Lead Sponsor: Tehran University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: All

Target Recruitment: 60

Inclusion Criteria

Age over 18 years
Getting infected with covid 19 disease (SARS_COV_2 PCR POSITIVE)
Patients who are hospitalized in the course of the disease
Spo2 under 90%
On the CT scan of lung, the evidences of covid 19 are presented
Not being admitted at the ICU, on the first visit, at the start of ozone therapy

Exclusion Criteria

Age less than 18 years
Pregnancy
Breastfeeding
Intubated patient on the first visit at the start of ozone therapy
Album below 3.5
Presence of underlying diseases (liver, kidney, hyperthyroidism, hypothyroidism, heart disease)

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Respiratory status. Timepoint: Daily. Method of measurement: With pulse oximetry device.

Secondary Outcome Measures

Name	Time	Method
Radiological changes in CT scan. Timepoint: Start of study, two weeks later. Method of measurement: Chest CT Scan.;Mortality rate. Timepoint: Start of study, two weeks later. Method of measurement: Patient's clinical condition.;Hospitalization rate in ICU. Timepoint: Start of study, two weeks later. Method of measurement: Evaluation of the patient's clinical condition.;Inflammatory factors. Timepoint: Start of study, two weeks later. Method of measurement: blood test.